BHVN: Biohaven Net earnings per share (EPS TTM)
Biohaven Ltd. adheres to industry waste disposal compliance by integrating ESG standards and bioethics into the development of neurological drugs. The annual EPS TTM snapshot demonstrates profit dynamics, where the current parameter equals -3.82. The company is betting on the expansion of its small molecule platform and the rapid market launch of treatments for mental disorders.
%20%5Blogo%5D%20BHVN&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_BHVN_-_Biohaven-Ltd._-_Net-earnings-per-share-EPS-TTM "BHVN Biohaven Corp: Net earnings per share for the last 12 months in the range 07/04/2022 - 11/12/2026 | 👁️GURU.Markets👁️")
Financial and market metric breakdowns for Biohaven Ltd (BHVN)
- stock price and consensus target price:
- market capitalization information:
- business book valuation details:
- debt level and financial liquidity data:
Debt to Equity Biohaven Ltd.|BHVN - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Biohaven Pharmaceutical|BHVN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Biohaven Ltd.|BHVN - Company Long-Term Debt|Company Current Liabilities Biohaven|Quick Ratio biohavenpharma.com
- earnings and valuation multiples indicators:
BHVN - Company Profit|Future Profit Biohaven Ltd.|BHVN - Business Payback Period|Forward P/E Multiple Biohaven|BHVN - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Biohaven Ltd.|BHVN - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Biohaven|BHVN - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months biohavenpharma.com|BHVN - Earnings per share growth this year|Net earnings per share growth forecast for next year Biohaven Ltd.
General company analysis:BHVN - Biohaven Ltd.
By outsourcing production and testing, Biohaven Ltd. (BHVN) minimizes capital expenditures, which directly impacts the efficiency of its profit generation. By analyzing the TTM net income per share, an investor assesses the actual earnings per share over the year, determining the business's ability to scale without inflating the share base and confirming the sustainability of the asset's long-term value growth.
Competitor analysis for Biohaven Ltd.
Biogen Inc. - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NBIX (neurocrine.com)|RGC: Net earnings per share (EPS TTM)|Axsome (AXSM) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months ACAD|Earnings per share for the last twelve months XENE|Net earnings per share (EPS TTM) VKTX|SUPN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months Catalyst Pharmaceuticals, Inc. CPRX|DNLI: Earnings per share for the last 12 months|HRMY: Net earnings per share for the last 12 months|Earnings per share for the trailing year AMLX (Amylyx Corp)|Trevi Therapeutics (TRVI) - Earnings per share for the last twelve months|PRAX (praxismedicines.com) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months AVXL|CBLL (CeriBell Inc) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) PRTA|alector.com - Earnings per share for the last 12 months|Annexon, Inc. - Net earnings per share for the last 12 months|Net earnings per share for the last four quarters Omeros Corp (OMER)|Neurogene - Net earnings per share (EPS TTM)|ACIU: Earnings per share for the last twelve months|VYGR: Net earnings per share (EPS TTM)|Neumora Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months SCLX|Earnings per share for the last twelve months TVGN|Earnings per share for the last twelve months Alpha Cognition (ACOG)|Cognition Therapeutics Inc. - Earnings per share for the last 12 months|Earnings per share for the last twelve months Inhibikase IKT|SAVA: Earnings per share for the last 12 months|Assertio Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Coya Therapeutics, Inc.|VTGN (vistagen.com) - Net earnings per share for the last 12 months|Ovid Therapeutics (OVID) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Acumen Pharma|CRVO: Earnings per share for the trailing year|Earnings per share for the last twelve months Alterity Therapeutics (ATHE)|CLNN - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) PEPG (PepGen)|Jupiter Neurosciences, Inc. - Earnings per share for the last twelve months|Relmada - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Annovis Bio Corporation ANVS|gracetx.com (GRCE) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months fireflyneuro.com (AIFF)|KLTO (ANEW Medical) - Net earnings per share (EPS TTM)|NRSN: Earnings per share for the trailing year|Net earnings per share (EPS TTM) RVPH|Net earnings per share (EPS TTM) metaviatx.com (MTVA)|NeurAxis, Inc. - Net earnings per share for the last 12 months|Helius Medical Technologies, Inc. - Earnings per share for the last twelve months|Passage Bio Corp - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Neuphoria Therapeutics Inc.|Minerva Neurosciences Corp (NERV) - Earnings per share for the last twelve months|Earnings per share for the last 12 months ATHA|Net earnings per share for the last 12 months ADXN|ALZN: Earnings per share for the trailing year|Earnings per share for the last twelve months Cyclerion Therapeutics (CYCN)|Earnings per share for the last twelve months PTIX (protagenic.com)|Pasithea Therapeutics Corp. - Net earnings per share for the last 12 months|Earnings per share for the last four quarters CRGT (Cortigent Inc)|Avenue Therapeutics - Net earnings per share (EPS TTM)|BCLI (brainstorm-cell.com) - Earnings per share for the last 12 months|CARA (Cara Therapeutics) - Net earnings per share for the last 12 months|CHRO - Net earnings per share for the last four quarters|ELYM (Eliem Therapeutics, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ITCI|Net earnings per share (EPS TTM) LBPH|MRNS (marinuspharma.com) - Earnings per share for the trailing year|NKGen Biotech - Net earnings per share for the last 12 months|NeuroBo Pharmaceuticals Inc - Earnings per share for the last twelve months|SAGE - Earnings per share for the last twelve months|SNPX (Synaptogenix, Inc) - Earnings per share for the last 12 months|Trevena, Inc. (TRVN) - Earnings per share for the last twelve months|Earnings per share for the last 12 months VIGL|WENA (Anew Medical) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Cerevel Therapeutics Inc CERE
